Background illustration for clinical trials search

Paid Clinical Trials Bradenton

Discover 1,438 paid clinical trials in Bradenton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

for
Esophageal Squamous Cell Carcinoma,
Location: Sarasota FL, Denver CO, Nashville TN, Houston TX,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07503808

Phase1, Recruiting

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

for
Chronic Lymphocytic Leukemia (CLL),
Location: Sarasota FL, Coral Gables FL, Winston-Salem NC,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07221500

Phase2, Recruiting

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Sarasota FL, Durham NC, San Antonio TX, New York NY,
Sponsor: Bristol-Myers Squibb

Sex: Male

Age: 18+

Code: NCT06067841

Phase1, Recruiting

A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer

for
Prostatic Neoplasms
Location: Sarasota FL, Cleveland OH, New York NY
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07319871

Phase1, Recruiting

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

for
Head and Neck Squamous Cell Carcinoma HNSCC,
Location: Sarasota FL, Fairfax VA, Washington D.C. DC, Austin TX,
Sponsor: Sutro Biopharma, Inc.

Sex: All

Age: 18+

Code: NCT07227168

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

for
Advanced or Metastatic Adrenocortical Carcinoma,
Location: Sarasota FL, New York NY, Providence RI
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07189403

Phase1, Recruiting

A Study of LY4175408 in Participants With Advanced Cancer

for
Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma,
Location: Sarasota FL, Orlando FL, Nashville TN, Houston TX,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07046923

Phase1, Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

for
Advanced Solid Tumor
Location: Sarasota FL, Tampa FL, Houston TX, Pittsburgh PA,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07070232

Phase1, Phase2, Recruiting

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

for
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
Location: Sarasota FL, Miami FL, Durham NC, Nashville TN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06876649

Recruiting

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

for
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
Location: Sarasota FL, Miami FL, Atlanta GA, Durham NC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06876662

Recruiting

A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

for
Prostatic Neoplasms
Location: Sarasota FL, Cleveland OH, New York NY, Seattle WA
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT07082920

Phase1, Recruiting

A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors

for
Advanced Stage Solid Tumors
Location: Sarasota FL, Nashville TN, Fairfax VA, New York NY
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07107230

Phase1, Recruiting

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

for
HR+ Breast Cancer, Triple Negative Breast Cancer (TNBC),
Location: Sarasota FL, Denver CO, Houston TX, Fairfax VA,
Sponsor: NiKang Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07029399

Phase1, Recruiting

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

for
PROC, Platinum Resistant Ovarian Cancer, Endometrial Cancer
Location: Sarasota FL, Little Rock AR, Columbus OH, Dallas TX,
Sponsor: Whitehawk Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07470853

Phase1, Recruiting

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

for
Cancer, Advanced Cancer, Locally Advanced Carcinoma,
Location: Sarasota FL, Nashville TN, Houston TX, Fairfax VA,
Sponsor: Angiex, Inc.

Sex: All

Age: 18+

Code: NCT06440005

Phase1, Recruiting

A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

for
Metastatic Castration-resistant Prostate Neoplasms,
Location: Sarasota FL, St Louis MO, Philadelphia PA, Brooklyn NY,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT05818683

Phase1, Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

for
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer,
Location: Sarasota FL, Tampa FL, Nashville TN, Houston TX,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06128551

Phase1, Phase2, Recruiting

Study of AVZO-021 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor, HR+/HER2- Breast Cancer,
Location: Sarasota FL, Tampa FL, Fairfax VA, Dallas TX,
Sponsor: Avenzo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05867251

Phase1, Phase2, Recruiting

QTX3034 in Patients With KRAS G12D Mutation

for
Solid Tumors
Location: Sarasota FL, Tampa FL, Durham NC, Nashville TN,
Sponsor: Quanta Therapeutics

Sex: All

Age: 18+

Code: NCT06227377

Phase1, Recruiting

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic ER+ HER2- Breast Cancer (mBC),
Location: Sarasota FL, New Orleans LA, Nashville TN,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06784193

Phase1, Recruiting